BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 4399542)

  • 1. The role of central monoamines in decapitation convulsions of mice.
    Kamat UG; Sheth UK
    Neuropharmacology; 1971 Sep; 10(5):571-9. PubMed ID: 4399542
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanism of the central hypotensive action of guanethidine.
    Bhargava KP; Jaju BP; Tangri KK
    Br J Pharmacol Chemother; 1966 Sep; 27(3):491-6. PubMed ID: 4381966
    [No Abstract]   [Full Text] [Related]  

  • 3. Reserpine rigidity and adrenergic neurones.
    Morrison AB; Webster RA
    Neuropharmacology; 1973 Aug; 12(8):725-33. PubMed ID: 4795744
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies in vivo on the relationship between brain tryptophan, brain 5-HT synthesis and hyperactivity in rats treated with a monoamine oxidase inhibitor and L-tryptophan.
    Grahame-Smith DG
    J Neurochem; 1971 Jun; 18(6):1053-66. PubMed ID: 4254940
    [No Abstract]   [Full Text] [Related]  

  • 5. Proceedings: Pharmacology of the adrenergic mechanism.
    Pfeifer AK
    J Neural Transm; 1974; Suppl 11(0):163-80. PubMed ID: 4135935
    [No Abstract]   [Full Text] [Related]  

  • 6. Central actions of dopa and dopamine.
    Sourkes TL
    Rev Can Biol; 1972; 31():Suppl:153-68. PubMed ID: 4403289
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of dihydroxyphenylalanine on the serotonin content of rat brain following pretreatment with monoamine oxidase inhibitors].
    Popov N; Matthies H
    Acta Biol Med Ger; 1966; 17(5):637-43. PubMed ID: 5991588
    [No Abstract]   [Full Text] [Related]  

  • 8. The influence of sympathomimetic amines, monoamine oxidase inhibitors, and antihypertensives upon the energy metabolism in the rat heart.
    Hilliard WG; Oliver WT; Van Petten GR
    Can J Physiol Pharmacol; 1966 Jul; 44(4):605-13. PubMed ID: 5968213
    [No Abstract]   [Full Text] [Related]  

  • 9. The effects of monoamine oxidase inhibitors on spinal synaptic activity.
    Anderson EG; Baker RG; Banna NR
    J Pharmacol Exp Ther; 1967 Dec; 158(3):405-15. PubMed ID: 5299660
    [No Abstract]   [Full Text] [Related]  

  • 10. Induction of pseudopregnancy in rats by depletors of endogenous catecholamines.
    Coppola JA; Leonardi RG; Lippmann W; Perrine JW; Ringler I
    Endocrinology; 1965 Sep; 77(3):485-90. PubMed ID: 5891260
    [No Abstract]   [Full Text] [Related]  

  • 11. [Drugs with effect on the adrenergic nerve fiber].
    Haefely W
    Pharm Acta Helv; 1968 Dec; 43(12):757-75. PubMed ID: 4886667
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacologic effects of 2-phenylcycloalkylamines.
    McGrath WR; Kuhn WL
    Arch Int Pharmacodyn Ther; 1968 Apr; 172(2):405-13. PubMed ID: 5684251
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on the hypertensive response elicited by reserpine or tetrabenazine in rats treated with amphetamine-like drugs.
    Bonaccorsi A
    Eur J Pharmacol; 1968 May; 3(2):97-105. PubMed ID: 5666014
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of various neurohumoral modulators on the activity of morphine and the narcotic antagonists in the tail-flick and phenylquinone tests.
    Dewey WL; Harris LS; Howes JF; Nuite JA
    J Pharmacol Exp Ther; 1970 Nov; 175(2):435-42. PubMed ID: 4394803
    [No Abstract]   [Full Text] [Related]  

  • 15. On the nature of the adrenergic neuron extragranular amine binding site.
    Enna SJ; Shore PA
    J Neural Transm; 1974; 35(2):125-35. PubMed ID: 4152377
    [No Abstract]   [Full Text] [Related]  

  • 16. m-Fluorotyrosine convulsions and mortality: relationship to catecholamine and citrate metabolism.
    Weissman A; Koe BK
    J Pharmacol Exp Ther; 1967 Jan; 155(1):135-44. PubMed ID: 5297377
    [No Abstract]   [Full Text] [Related]  

  • 17. [Epilepsy and monoamines in the brain].
    Kobayashi K; Mori A
    Nihon Rinsho; 1975 Oct; 33(10):3074-84. PubMed ID: 1107618
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of pretreatment with monoamine oxidase inhibitors or (+)-amphetamine on leptazol convulsions in mice and rats.
    Turner TA; Spencer PS
    J Pharm Pharmacol; 1968 Dec; 20():Suppl:122S+. PubMed ID: 4388144
    [No Abstract]   [Full Text] [Related]  

  • 19. Neurochemical changes following the administration of depleters of biogenic monoamines.
    Lane JD; Smith JE; Shea PA; McBride WJ
    Life Sci; 1976 Dec; 19(11):1663-7. PubMed ID: 12434
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of dopaminergic and noradrenergic mechanisms in Metrazole convulsions in mice.
    Dadkar VN; Dahanukar SA; Sheth UK
    Indian J Med Res; 1979 Sep; 70():492-4. PubMed ID: 535961
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.